Cargando…
Therapeutic Effect of Tanshinone IIA on Liver Fibrosis and the Possible Mechanism: A Preclinical Meta-Analysis
BACKGROUND: Liver fibrosis is a serious human health problem, and there is a need for specific antifibrosis drugs in the clinic. Tanshinone IIA has recently been reported to have a role in the treatment of liver fibrosis. However, the evidence supporting its antifibrotic effect is not sufficient, an...
Autores principales: | Ying, Qingji, Teng, Yangyang, Zhang, Jing, Cai, Zhenzhai, Xue, Zhanxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930756/ https://www.ncbi.nlm.nih.gov/pubmed/31915451 http://dx.doi.org/10.1155/2019/7514046 |
Ejemplares similares
-
Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis
por: Ashour, Asmaa A, et al.
Publicado: (2021) -
Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms
por: Zhu, Peng-Chong, et al.
Publicado: (2023) -
Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats
por: HE, HUANYU, et al.
Publicado: (2015) -
Potential Therapeutic Roles of Tanshinone IIA in Human Bladder Cancer Cells
por: Chiu, Sheng-Chun, et al.
Publicado: (2014) -
Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
por: Zhai, Xifeng, et al.
Publicado: (2017)